Publications by authors named "Laura Giuseppina Giannetta"

The WHO Classification of Tumors, Thoracic Tumors, 5th edition, has outlined the use of TTF-1 and ΔNP63/P40 to discriminate between adenocarcinoma and squamous cell carcinoma. In 2015, the first description of a rare non-small cell lung carcinoma featuring co-expression of glandular and squamous differentiation within most of the same individual tumor cells was reported on, with ultrastructural and molecular demonstration of such a biphenotypic differentiation. We herein describe an additional case of this rare tumor entity, which is confirmed to be an aggressive neoplasm despite potential targets of therapy.

View Article and Find Full Text PDF
Article Synopsis
  • - ROS1 tyrosine kinase inhibitors (TKIs) are effective for patients with advanced ROS1-positive NSCLC but often face resistance, requiring new treatments.
  • - The F2004V mutation in ROS1 was found in a patient whose cancer progressed after using entrectinib and crizotinib.
  • - Treatment with the next-generation TKI repotrectinib resulted in a positive response, showcasing its effectiveness against the F2004V resistance mutation.
View Article and Find Full Text PDF